Stamford, CT - TSN Media Group announces the immediate availability of Proximity Health Solutions (PHS). Leveraging 20+ years of grass roots marketing experience, access to 20,000 local venues and community thought leaders, Proximity Health Solutions (PHS) conducts all recruiting, educational events and pre-screening within proximity of each client-designated investigator site.
Proximity Health Solutions provides a unique service, addressing the biggest gaps in clinical trials: attracting, educating and enrolling qualified, engaged, and diverse participants.
“We’ve seen clinical trial outcomes continue to be marginalized as a result of recruitment not meeting objectives, subjects not in proximity to investigator sites, and participants unaware of study expectations,” says Vera Rulon MS, RHIT, FAHIMA, PHS’s Chief Content Officer. “At Proximity Health Solutions we apply a unique approach that converges local influencers and thought leaders with local investigators to build relationships with patients. We meet patients where they are, engage them in settings where they feel comfortable and educate them about a specific local clinical trial in which to enroll.”
PHS will support research and development teams at pharmaceutical and biotechnology manufacturers that sponsor clinical trials for new drug development, government organizations looking to educate citizens about public health issues and healthcare options, as well as clinical trial research organizations that conduct clinical trials.
About Proximity Health Solutions
Proximity Health Solutions (PHS) is a newly formed division of TSN Media Group. PHS works with clinical trial sponsors and contract research organizations (CROs) to understand their recruitment goals and align on a strategy. PHS formulates individualized, grass roots recruitment plans which utilize local influencers, thought leaders, community venues and local media to engage and recruit qualified patients within proximity of client designated clinical trial investigator sites. On-line and live educational events are conducted to educate potential enrollees about medical conditions and specific details of each clinical trial study. Local investigator site personnel are encouraged to participate in educational events to begin to establish a relationship with patients. Patient prescreening is conducted during recruitment process and at conclusion of each educational event.
About TSN Media Group
Founded in 1991, TSN Media Group is a health and wellness marketing and media services company focusing on products and services for the mature consumer. The company provides clients reach and access to this mature consumer audience utilizing a combination of traditional, digital and online media.
TSN has executed more than 500 individual brand assignments in 38 healthcare categories, representing a prestigious client base that includes major healthcare companies, pharmaceutical companies, government agencies and clinical research organizations (CRO).
For More Information Please Contact:
Jeff Schwarz – VP Marketing
O: 203-969-2700 C: 201-665-0899
E: jschwarz@proximityhealthsolutions.com
W: www.ProximityHealthSolutions.com
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
The State of the Opioid Epidemic
March 26th 2024In part 1 of this video interview, Greg Sturmer, co-founder and CEO of Elysium Therapeutics discusses the current state of opioid usage including how pain treatment is often mismanaged and how the industry can adopt greater safety standards in developing pain therapies.